June 11, 2024

The cardiac biomarkers market has reached a significant milestone, valued at approximately USD 11.35 billion in 2023. With a projected compound annual growth rate (CAGR) of 9.90%, the market is poised to reach around USD 26.55 billion by 2032. This growth is driven by advancements in diagnostic technologies, increasing prevalence of cardiovascular diseases, and heightened […]

Read More